DYN Straddle Strategy

DYN (Dyne Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.

DYN (Dyne Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.46B, a beta of 1.08 versus the broader market, a 52-week range of 8.06-25, average daily share volume of 1.7M, a public-listing history dating back to 2020, approximately 192 full-time employees. These structural characteristics shape how DYN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.08 places DYN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a straddle on DYN?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current DYN snapshot

As of June 30, 2026, spot at $22.41, ATM IV 120.70%, IV rank 22.08%, expected move 34.60%. The straddle on DYN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this straddle structure on DYN specifically: DYN IV at 120.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a DYN straddle, with a market-implied 1-standard-deviation move of approximately 34.60% (roughly $7.75 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DYN expiries trade a higher absolute premium for lower per-day decay. Position sizing on DYN should anchor to the underlying notional of $22.41 per share and to the trader's directional view on DYN stock.

DYN straddle setup

The DYN straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DYN near $22.41, the first option leg uses a $22.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DYN chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DYN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$22.50$1.24
Buy 1Put$22.50$1.30

DYN straddle risk and reward

Net Premium / Debit
-$254.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$251.24
Breakeven(s)
$19.96, $25.04
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

DYN straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on DYN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

DYN straddle profit and loss curve at expiration with breakevens and current spot markedDYN straddle payoff at expiration$0$500$1000$1500$10$20$30$40Underlying Price ($)P&L at Expiration ($)BE $19.96BE $25.04Spot $22.41
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$1,995.00
$4.96-77.8%+$1,499.61
$9.92-55.7%+$1,004.23
$14.87-33.6%+$508.84
$19.83-11.5%+$13.45
$24.78+10.6%-$26.07
$29.73+32.7%+$469.32
$34.69+54.8%+$964.71
$39.64+76.9%+$1,460.10
$44.59+99.0%+$1,955.48

When traders use straddle on DYN

Straddles on DYN are pure-volatility plays that profit from large moves in either direction; traders typically buy DYN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

DYN thesis for this straddle

The market-implied 1-standard-deviation range for DYN extends from approximately $14.66 on the downside to $30.16 on the upside. A DYN long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current DYN IV rank near 22.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DYN at 120.70%. As a Healthcare name, DYN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DYN-specific events.

DYN straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DYN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DYN alongside the broader basket even when DYN-specific fundamentals are unchanged. Always rebuild the position from current DYN chain quotes before placing a trade.

Frequently asked questions

What is a straddle on DYN?
A straddle on DYN is the straddle strategy applied to DYN (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With DYN stock trading near $22.41, the strikes shown on this page are snapped to the nearest listed DYN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DYN straddle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the DYN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 120.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$251.24 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DYN straddle?
The breakeven for the DYN straddle priced on this page is roughly $19.96 and $25.04 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DYN market-implied 1-standard-deviation expected move is approximately 34.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on DYN?
Straddles on DYN are pure-volatility plays that profit from large moves in either direction; traders typically buy DYN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current DYN implied volatility affect this straddle?
DYN ATM IV is at 120.70% with IV rank near 22.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related DYN analysis